ALLERFUND VENTURES, LLC
ALLERFUND VENTURES, LLC is a Seed and Series A fund in the US, Belgium and Switzerland investing in Healthcare, life-sciences, biotechnology, medical-devices, diagnostics, consumer-products and digital-tech.
- Stages
- Seed, Series A
- Sectors
- Healthcare, life-sciences, biotechnology, medical-devices, diagnostics, consumer-products, digital-tech
- Invests in
- US-wide, Belgium, Switzerland
- Actively investing
- Yes
- Founded
- 2020
Check size not disclosed
Thesis
AllerFund Ventures, established in 2020 and headquartered in Scarsdale, New York, is a venture capital firm dedicated to investing in early-stage companies (Seed and Series A) that develop innovative solutions for the food allergy community. Operating as a for-profit entity, the firm aims to accelerate the commercialization of new treatments, diagnostics, and products. Their geographic focus is primarily the United States, with some investments in Belgium and Switzerland. The investment strategy centers on therapeutics, medical devices, diagnostics, digital technologies, and consumer products within the life sciences sector, emphasizing potential clinical and community impact. While AUM is not disclosed, they have made 18 investments as of September 2025. AllerFund I is a closed early-stage venture capital fund. They are registered as an SEC-registered investment adviser.
Common questions
Does ALLERFUND VENTURES, LLC invest at the Seed stage?
Yes. ALLERFUND VENTURES, LLC lists Seed and Series A among the stages it invests in.
Where does ALLERFUND VENTURES, LLC invest?
ALLERFUND VENTURES, LLC invests in the US, Belgium and Switzerland.